Tag: Pharmaceuticals
-
AstraZeneca stock dives 9% after heart drug trial misses target
Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenu Shares of AstraZeneca fell as much as 9% after a late stage clinical trial for an experimental heart disease failed to meet
-
Jim Cramer says this former Covid market darling is finally investable again
CNBC’s Jim Cramer said Moderna’s expanding pipeline in treatments for cancer and other diseases provides a compelling long-term investment thesis.
-
Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare
Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to drugmakers.
-
Medicare will start covering obesity drugs for the first time. Here’s what patients should know
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
-
French biotech stock soars 25% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
-
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.
-
Chan Zuckerberg Initiative’s Biohub to open new rare disease funding round
Chan Zuckerberg Initiative’s Biohub will offer new grants to the rare disease community while expanding its AI drug repurposing partnership with Every Cure.
-
U.S. Treasury will oversee frozen Iranian funds when they’re released, Bessent says
Treasury Secretary Scott Bessent said once Iranian frozen assets are released, they will be overseen by Treasury and routed largely to U.S. agriculture, medicines.
-
U.S. opens tariff probe targeting Germany’s drug pricing policies
U.S. Trade Representative Jamieson Greer said Germany’s proposal to reduce spending on medicines was “a serious step backwards.”
-
Zealand Pharma stock suffered its two worst days on record. Here’s what’s next for the weight loss drugmaker
While the market’s enthusiasm for one of Zealand’s experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
